HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


DSHEA “Defense” To Be Supported By Supplement Industry Lobbying Day

This article was originally published in The Tan Sheet

Executive Summary

A dietary supplement industry mass lobbying effort scheduled for Oct. 21 aims to fight the "supplement safety" bill and back the Dietary Supplement Health & Education Act "full implementation" bill

You may also be interested in...

THG Controversy Spotlights Growing Sports Supplement Concerns

FDA's ban of tetrahydrogestrinone (THG) represents another black eye for sports supplements, coinciding with the highly publicized debate over the safety of ephedra-containing products

DSHEA Bills To Receive Congressional Consideration As Year Ends – CRN

Legislation focused on the Dietary Supplement Health & Education Act will gain momentum in the latter half of the year, members of the Council for Responsible Nutrition forecast at the group's annual meeting in Tucson, Ariz. Sept. 15

DSHEA Implementation Would Get Funding Push Under Harkin/Hatch Bill

FDA funding of $20 mil. in FY 2004 would be authorized for implementation of the Dietary Supplement Health & Education Act under a bill introduced July 31 by Sen. Tom Harkin (D-Iowa)

Related Content





Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts